Terms.

PEP/NEWS curates and links to peptide research. The brief itself — the editorial selection and gloss prose — is licensed liberally. The source articles we link to live at their own URLs and follow their own licenses. Nothing here is medical advice.

Use of the brief.license

Original PEP/NEWS curation (the daily selection, headlines, gloss/blurb prose, and editorial commentary) is licensed under Creative Commons Attribution 4.0 International (CC-BY 4.0). You can quote, mirror, embed, train an LLM on, or otherwise reuse it — as long as you attribute "PEP/NEWS, https://pep.news/" and do not imply endorsement.

Linked source articles, videos, journal papers, and biotech-wire pieces are not ours to license. Each source URL governs the use of its own content under that publisher's terms.

Editorial selection.methodology

The day's brief is assembled by an automated pipeline that pulls from a curated list of peptide-research RSS feeds, biotech industry wires, and physician-researcher YouTube channels. A large-language model (currently Claude Sonnet 4.6) reviews the candidate set and selects the day's hero, features, and "more" entries. Human editorial oversight reviews the pipeline's prompts and source list, not the day-by-day output.

Selections are made on relevance to peptide research, biological mechanism, and clinical signal — not on advertiser interest, affiliate revenue, or social-media performance. We have no advertisers and no affiliate program on PEP/NEWS itself.

Not medical advice.research-only

PEP/NEWS aggregates and curates published research, clinical trial readouts, and educational content. Nothing on this site is medical advice, dosing guidance, a sourcing recommendation, or a substitute for a licensed physician. Peptides discussed are for laboratory and educational reference. Consult a qualified physician before any therapeutic decision.

Warranty disclaimer.limitation

The brief is provided "as is." We make no representation that any linked source is accurate, current, or appropriate for any purpose. Use of the information here is at your own discretion and risk. To the maximum extent permitted by law, we disclaim all liability for direct, indirect, incidental, consequential, or special damages arising from use of the site.

Severability.governing law

If any provision of these terms is held invalid or unenforceable, the remainder continues in effect. These terms are governed by the laws of the State of Hawaii, United States, without regard to conflict-of-laws principles.

Contact.changes

For tip submissions, corrections, or licensing questions outside CC-BY 4.0, file an issue on the public repository: github.com/researchvialsus-stack/pep.news/issues.

If anything in these terms changes, we'll update this page and link to the change. There is no fine print.

Last updated: 2026-05-09